Abstract
SummaryThe use of destabilizing domains (DDs) to conditionally control the abundance of a protein of interest (POI) through a small-molecule stabilizer has gained increasing traction both in vitro and in vivo. Yet there are specific considerations for the development and accurate control of user-defined POIs via DDs, as well as the identification of novel (and potentially synergistic) small-molecule stabilizers. Here, we describe a platform for achieving these goals.For complete details on the use and execution of this protocol, please refer to Ramadurgum et al. (2020).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have